SOMERSET, N.J., May 11 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. today announced that Eran Broshy, Chairman and Chief Executive Officer, and David Bassin, newly-appointed Chief Financial Officer, will make a presentation at the Bank of America Smid Cap Conference taking place at the Four Seasons in Boston May 16 - 17, 2007.
Bank of America will welcome investors to a diversified Small and Mid Cap idea forum where 70 companies with market cap ranges from $500 million to $8 billion will present. The conference is designed to give investors unique access to company management teams and to provide a broad platform for analysts and portfolio managers to collect new investment ideas.
inVentiv’s presentation will take place on Wednesday, May 16 at 8:50 a.m. EDT in the Winthrop Room at the Four Seasons Hotel. An audio webcast of the presentation can be accessed by logging on to http://www.inventivhealth.com/health/newsroom/webCasts.asp.
About inVentiv Health
inVentiv Health is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
inVentiv Health, Inc.
CONTACT: Investors & Corporate, David Bassin, CFO, +1-732-537-4804, orinvestor@inventivhealth.com, or Media, Felicia Vonella, +1-212-308-7155, orfvonella@inventivhealth.com, both of inVentiv Health, Inc.
